SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-18-003193
Filing Date
2018-01-22
Accepted
2018-01-22 08:36:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 8-K a18-3546_28k.htm 425 67122
2 EX-2.1 a18-3546_2ex2d1.htm EX-2.1 1046798
3 EX-3.1 a18-3546_2ex3d1.htm EX-3.1 8846
4 EX-10.1 a18-3546_2ex10d1.htm EX-10.1 34408
5 EX-99.1 a18-3546_2ex99d1.htm EX-99.1 71041
  Complete submission text file 0001104659-18-003193.txt   1229915
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filed by) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-31918 | Film No.: 18538856
SIC: 2836 Biological Products, (No Diagnostic Substances)